Scinovex
Subscribe
A

Andreas Hochhaus

Jena University HospitalORCID https://orcid.org/0000-0003-0626-0834
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Leukemia20223,654 citationsCorresponding
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Leukemia20223,466 citations
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Blood20131,979 citations
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Leukemia20201,470 citationsFirst authorCorresponding
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Leukemia2002901 citationsFirst authorCorresponding
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
Leukemia2016845 citationsFirst authorCorresponding
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
Leukemia2009843 citationsFirst authorCorresponding
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects
Leukemia2003553 citations
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Leukemia2016470 citations
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
Leukemia2012437 citations
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Leukemia2012416 citations
Andreas Hochhaus · Scinovex